Immunovant, Inc. Banner Image

Immunovant, Inc. has reached its limit for free report views

Work for Immunovant, Inc.? Upgrade Your Profile and unlock all your annual reports.

Immunovant, Inc.

  • Ticker IMVT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Immunovant, Inc. Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.
Immunovant, Inc.

Most Recent Annual Report

Immunovant, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Report Locked. Immunovant, Inc. has reached its limit for free report views.

Older/Archived Annual Reports

Immunovant, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!